Corestreet Logo

BioCryst Pharmaceuticals Inc (BCRX) Insider Trading

Total insider buys:
  • $10,606,554.40
Total insider sells:
  • $40,886,919.76
Most recent insider trade:
  • June 24, 2024
Most active insider trader:
  • Thomas R Staab II
Trader NameDateTitleAmountPriceTypeTotal Value
June 24, 2024Director8,600$6.32Sell$54,352.00
June 17, 2024Director4,689$6.00Sell$28,134.00
May 30, 2024Director7,861$6.36Buy$49,995.96
May 24, 2024Director2,500$6.40Buy$16,000.00
May 20, 2024Director5,000$6.38Buy$31,900.00
May 14, 2024Insider30,000$5.86Buy$175,800.00
May 14, 2024CFO36,300$5.57Buy$202,191.00
May 13, 2024Director21,940$5.49Buy$120,450.60
June 15, 2023Director4,000$7.98Sell$31,920.00
Feb. 1, 2023CEO100,000$10.38Sell$1,038,000.00
Dec. 15, 2022Director445$10.90Sell$4,850.50
Dec. 15, 2022Insider3,125$10.89Sell$34,031.25
Dec. 15, 2022CEO14,100$10.90Sell$153,690.00
Dec. 15, 2022CFO5,700$10.90Sell$62,130.00
Dec. 2, 2022CEO82,656$12.80Sell$1,057,996.80
Dec. 1, 2022Director8,600$13.01Sell$111,886.00
Nov. 14, 2022Insider31,515$13.88Sell$437,428.20
April 1, 2022Insider7,600$16.20Sell$123,120.00
Feb. 15, 2022Director5,000$18.50Sell$92,500.00
Jan. 11, 2022CEO184,000$15.04Sell$2,767,360.00
Dec. 7, 2021Insider30,100$12.20Sell$367,220.00
Nov. 24, 2021Director7,500$12.19Buy$91,425.00
Nov. 23, 2021CFO35,258$12.48Buy$440,019.84
Nov. 15, 2021Director5,000$12.27Sell$61,350.00
Oct. 15, 2021Director105,000$15.40Sell$1,617,000.00
Sept. 10, 2021Director74,000$15.09Sell$1,116,660.00
July 15, 2021Director5,000$15.69Sell$78,450.00
May 27, 2021Insider71,759$15.00Sell$1,076,385.00
May 24, 2021Director6,667$13.90Sell$92,671.30
May 10, 2021Director7,000$12.70Sell$88,900.00
Dec. 11, 2020VP13,741$7.96Sell$109,378.36
Dec. 4, 2020VP13,741$6.23Sell$85,606.43
Aug. 11, 2020CFO54,000$4.08Buy$220,320.00
Nov. 18, 2019CEO50,000$1.45Buy$72,500.00
Nov. 18, 2019VP20,000$1.45Buy$29,000.00
Nov. 18, 2019Insider45,000$1.45Buy$65,250.00
Nov. 18, 2019Director5,000$1.45Buy$7,250.00
May 22, 2019Director3,000$3.57Buy$10,710.00
May 17, 2019Insider9,750$7.65Sell$74,587.50
May 15, 2019Insider11,750$7.81Sell$91,767.50
May 13, 2019Insider19,500$7.70Sell$150,150.00
May 9, 2019CFO9,750$7.63Sell$74,392.50
May 6, 2019CFO9,000$7.75Sell$69,750.00
May 2, 2019CFO7,750$7.30Sell$56,575.00
April 4, 2019Insider7,500$8.81Sell$66,075.00
March 12, 2019Director2,000$8.30Buy$16,600.00
Jan. 28, 2019CFO5,000$9.85Sell$49,250.00
Jan. 28, 2019VP12,000$9.75Sell$117,000.00
Jan. 25, 2019VP6,000$9.60Sell$57,600.00
Jan. 18, 2019VP2,000$9.40Sell$18,800.00
First«1 of 3»Last

  • Insiders are both buying and selling BioCryst Pharmaceuticals Inc stock.

  • The insider traders at BioCryst Pharmaceuticals Inc are: Thomas R Staab II, Lynne Powell, William P Sheridan, Alane P Barnes, Bros. Advisors Lp Baker, George B Abercrombie, Jon P Stonehouse, Yarlagadda S Babu, Anthony Doyle, Helen M Thackray, Nancy J Hutson, Steve Aselage, Machelle Sanders, Michael L Jones, Peder Jensen, Steven K Galson, Amy E Mckee, Thomas Staab II, Felix Baker, Fred E Cohen, Vincent Milano, George Abercrombie, George B. Abercrombie, Alan G Levin, Kenneth B Lee Jr, Kenneth Lee, Jr., and Megan Sniecinski

  • The most active insider trader at BioCryst Pharmaceuticals Inc is Thomas R Staab II with 35 trades.

  • Bros. Advisors Lp Baker has sold the most BioCryst Pharmaceuticals Inc stock with a total value of $40,465,900.00.

  • Felix Baker has bought the most BioCryst Pharmaceuticals Inc stock with a total value of $10,000,003.20.

  • The most recent insider trade for BioCryst Pharmaceuticals Inc was on June 24, 2024.

  • The single biggest insider buy for BioCryst Pharmaceuticals Inc was from Felix Baker with a total value of $5,000,001.60 on Aug. 1, 2013.

  • The single biggest insider sell for BioCryst Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $20,232,950.00 on Aug. 16, 2016.